Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways-Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways

Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways

Video Transcription

Video Summary

Thank you to all the speakers for their informative presentations. They discussed various topics related to breast cancer, including studies on aromatase inhibitors, hormone receptor expression, immune responses, and the role of cholesterol in breast cancer progression. Some key findings from the presentations include the discovery of a new protein called aromatase interacting partner in breast, or AIPB, which regulates aromatase catalytic activity and estrogen synthesis. Another study found that ABCA1, a protein involved in cholesterol transport, is associated with better prognosis in breast cancer patients. Furthermore, research showed that androgen receptor-regulated factors, such as PIP and kinase, can impact macrophage function and immune response in breast cancer. These findings provide insights into potential therapeutic targets and biomarkers for breast cancer.

Keywords

breast cancer

aromatase inhibitors

hormone receptor expression

immune responses

cholesterol

ABCA1

prognosis

androgen receptor-regulated factors

macrophage function

therapeutic targets


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274